Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Color Additives: Legislative Perspective in the United States, Europe, Australia, and India

Author(s):  Kumar Anuj, Madan Anil K

Issue:  Jul/Aug 2014 - Volume 18, Number 4
View All Articles in Issue

Page(s):  293-300

Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 1
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 2
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 3
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 4
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 5
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 6
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 7
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 8

Download in electronic PDF format for $75

Abstract:  In most countries, their regulatory bodies which control food, drugs, and cosmetics are responsible for regulating all the color additives to ensure that they are safe with those products, ensuring that they contain only approved ingredients, and that they are accurately labeled. Permitted colors are subject to rigorous safety standards prior to their approval and prior to the release of their specific use. Although a colorant may have approval in several countries, its use, level of use, specifications, acceptance criteria, and labeling requirements may differ from one country to another. In this review, we have explored the legislative and regulatory framework regarding the color additives for use in drugs and cosmetics.

Related Keywords: Anuj Kumar, MPharm, Anil K. Madan, PhD, color additives, pharmacy regulation, drug safety, colorant, United States, patient acceptance, patient adherence, patient compliance, legislation, dye, pigment, certification, Europe, purity criteria, European Union, Australia, India

Related Categories: EXCIPIENTS, LEGAL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Kumar Anuj
, Madan Anil K
Jul/Aug 2014
Pg. 293-300

Selection of Color Additives: A Regulatory View
Kumar Anuj
, Dureja Harish, Madan Anil K
Jul/Aug 2012
Pg. 304-309

Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
McElhiney Linda F
May/Jun 2009
Pg. 224-229

Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
Jul/Aug 2014
Pg. 318-319

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
Mar/Apr 2020
Pg. 92

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
May/Jun 2020
Pg. 180

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Compounding for the Pediatric Patient
Allen Loyd V Jr
Mar/Apr 1997
Pg. 84-86

Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn
, Reed-Kane Dana
Jul/Aug 2003
Pg. 258-263

Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris
, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Mar/Apr 2010
Pg. 165-170

Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2010
Pg. 328-331

Medications Discontinued in the United States
Ashworth Lisa D
Nov/Dec 2002
Pg. 441-442

Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
Nov/Dec 2003
Pg. 441-447

Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations
Branvold Andrea
, Barner Jamie C
Nov/Dec 2003
Pg. 490-494

Patient Access Is a Patient Safety Issue
Pore David
Mar/Apr 2019
Pg. 120-121

United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
Jul/Aug 2013
Pg. 283-288

Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B
, Fontane Patrick E, Day Jonathan R
Jul/Aug 2013
Pg. 339-343

Drug Utilization Review: Our Patients Deserve Our Very Best
Jackson Kathleen
Nov/Dec 2023
Pg. 450-453

Bedside Manner: Not Just for Doctors Anymore
Cormier Mindy
Mar/Apr 2015
Pg. 115-118

Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
Sep/Oct 2016
Pg. 367-374

Return to Top